IDH2 and astrocytoma (excluding glioblastoma): Further analyses showed that CDK4 amplifications are common among IDH-mut astrocytomas with poor prognosis, and their combination with chromosome 14 loss predicted an even shorter overall survival (OS) (40, 45).